Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis
Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi
Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi
View: Text | PDF
Research Article Oncology

Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis

  • Text
  • PDF
Abstract

The histone demethylase PHF8 has been implicated in multiple pathological disorders, including X-linked mental retardation and tumorigenesis. However, it is not clear how the abundance and function of PHF8 are regulated. Here, we report that PHF8 physically associates with the deubiquitinase USP7. Specifically, we demonstrated that USP7 promotes deubiquitination and stabilization of PHF8, leading to the upregulation of a group of genes, including cyclin A2, that are critical for cell growth and proliferation. The USP7-encoding gene was also transcriptionally regulated by PHF8, via positive feedback. USP7 was overexpressed in breast carcinomas, and the level of expression positively correlated with expression of PHF8 and cyclin A2 and with the histological grade of breast cancer. We showed that USP7 promotes breast carcinogenesis by stabilizing PHF8 and upregulating cyclin A2 and that the interaction between USP7 and PHF8 is augmented during DNA damage. Moreover, USP7-promoted PHF8 stabilization conferred cellular resistance to genotoxic insults and was required for the recruitment of BLM and KU70, which are both essential for DNA double-strand break repair. Our study mechanistically links USP7 to epigenetic regulation and DNA repair. Moreover, these data support the pursuit of USP7 and PHF8 as potential targets for breast cancer intervention, especially in combination with chemo- or radiotherapies.

Authors

Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi

×

Figure 6

USP7-promoted PHF8 stabilization is involved in DNA damage response.

Options: View larger image (or click on image) Download as PowerPoint
USP7-promoted PHF8 stabilization is involved in DNA damage response.
(A)...
(A) MCF-7 cells exposed to IR (6 Gy, left panel) or NCS (0.5 μg/ml for 1 hour, right panel) were collected at the indicated time points and analyzed by Western blotting with γH2AX as a positive control. (B) Total RNA was collected from MCF-7 cells exposed to IR or NCS followed by qRT-PCR analysis of PHF8 expression. (C) MCF-7 cells transfected with control siRNA or USP7 siRNA were exposed to IR and collected at the indicated time points. The expression of the indicated proteins was examined by Western blotting. (D) MCF-7 cells (top panel) or HeLa cells (bottom panel) were exposed to IR. Two hours after IR, cellular extracts were immunoprecipitated and then immunoblotted with antibodies against the indicated proteins. (E) HeLa cells stably expressing FLAG-PHF8 were cotransfected with HA-Ub/WT and the indicated siRNAs (left panel) or expressing vectors (right panel) followed by IR treatment. Cellular extracts were immunoprecipitated with anti-FLAG and then immunoblotted with anti-HA. (F) MCF-7, T47D, or ZR-75-1 cells expressing the indicated shRNAs were cocultured with their corresponding GFP-expressing cells, exposed to IR or NCS, and analyzed by FACS after 10 days. The percentage of GFP-negative cells relative to the GFP-positive cells under IR or NCS treatment was normalized to that in untreated control mixture, and the ratio is used to reflect cellular fitness. (G) MCF-7 cells expressing the indicated shRNAs and Dox-inducible PHF8 (left panel) or USP7 (right panel) were cocultured with GFP-expressing MCF-7 cells, exposed to IR or NCS, and analyzed by FACS after 10 days. In B, F, and G, each bar represents the mean ± SD for biological triplicate experiments. *P < 0.05, **P < 0.01, 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts